MET

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, MET mutation is significantly associated with the RNA expression of many other genes, with 8,802 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible MET-associated genes across cancer lineages are ERH, PSMC3IP, and WRAP53. Each is linked with MET in more than 4 cancer types. Because this analysis shows association rather than direction, both MET-to-partner and partner-to-MET results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, ERH grouped by MET-low versus MET-high in BLCA.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (MET→partner) and Y-score (partner→MET) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLCAERH →+0.421+3.212.002.00935
UCECPSMC3IP →+0.746+1.702<.001<.00134
COADWRAP53 →+0.523+3.652<.001.00134
UCECRPL23AP82 →+0.421+1.425<.001<.00134
KIRPSNRPD3 →+0.385+3.853.001<.00134
UCECPHF5A →+0.557+2.169<.001<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest of 8,802 associations by consensus.

ERH by MET expression — BLCA

Box plot of ERH in MET-low vs MET-high samples in BLCA.

Explore this box plot interactively →

Exploration